Alibhai Imran Nizamudin
SEC insider (Form 3/4/5 filer). CIK 0002064884. Chief Executive Officer at Tvardi Therapeutics, Inc. (TVRD). 6 reported Form 4/5 transactions since Sep 2024; latest on Jan 29, 2026. Located in SUGAR LAND, TX.
Companies Alibhai Imran Nizamudin has filed insider reports for
- Tvardi Therapeutics, Inc. (TVRD): Director, Officer, Chief Executive Officer
Alibhai Imran Nizamudin
CIK: 0002064884
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tvardi Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jan 29, 2026TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
115K shares- - Dec 16, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
47.5K shares- - Apr 17, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
182.3K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
207.9K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Optyion (right to buy)
2K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
160.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 29, 2026 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 115,000 | - | - | Direct |
| Dec 16, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 47,500 | - | - | Direct |
| Apr 17, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 182,320 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 207,881 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Optyion (right to buy) | 2,011 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 160,940 | - | - | Direct |
1-6 of 6 transactions